FIELD: medicine.
SUBSTANCE: invention refers to a method of treating a condition or a disease, wherein the insulin administration is considered to be effective; the method involves administering effective doses of an insulin derivative representing insulin NεB29-(Nα-(HOOC(CH2)14CO)-y-L-GIu) des(B30) into a patient in need thereof, wherein the above insulin derivative has a prolonged time-action profile, and the above doses are to be administered every 24 to 336 hours.
EFFECT: treating by administering the above insulin through extended intervals of time and simplifying the therapeutic regimens for patient's comfort.
11 cl, 4 ex, 5 tbl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
INSULIN DERIVATIVES | 2004 |
|
RU2352581C2 |
INSULIN DERIVATIVES | 2004 |
|
RU2518460C2 |
PHARMACEUTICAL COMPOSITION | 2013 |
|
RU2670106C2 |
METHOD OF OBTAINING INSULIN ZINC COMPLEXES | 2011 |
|
RU2572214C2 |
INSULIN DERIVATIVE, SOLUBLE PROLONGED PHARMACEUTICAL COMPOSITION, METHOD OF PROLONGATION OF HYPOGLYCAEMIC EFFECT IN TREATMENT OF DIABETIC PATIENTS | 1994 |
|
RU2164520C2 |
PEPTIDE COMPOSITION CONTAINING PROPYLENE GLYCOL OPTIMAL FOR MANUFACTURING AND APPLICATION IN INJECTION DEVICES | 2004 |
|
RU2421238C2 |
INSULIN PURIFICATION | 2012 |
|
RU2603752C2 |
METHOD OF CONJUGATING PEPTIDES, MEDIATED BY TRANSGLUTAMINASE | 2005 |
|
RU2385879C2 |
INSULIN PREPARATION CONTAINING NACL, PARENTERAL FINISHED FORM, METHOD FOR INCREASING CHEMICAL STABILITY OF INSULIN PREPARATION | 1997 |
|
RU2182015C2 |
INSULIN DERIVATIVE | 2007 |
|
RU2451029C2 |
Authors
Dates
2015-02-10—Published
2009-10-29—Filed